OBJECTIVES: To determine the incidence of postchemoradiotherapy (post-CRT) neck dissection (ND) complications; to ascertain whether timing (< 12 vs ≥ 12 weeks) from CRT to ND or other factors are associated with increased complications; and to determine whether ND timing influences disease control or survival. DESIGN: Ten-year retrospective analysis. SETTING: Tertiary care center. PATIENTS: One hundred five patients with head and neck cancer undergoing ND after CRT. MAIN OUTCOME MEASURES: Complications and survival variables compared between groups undergoing ND less than 12 weeks (less-than-12-weeks ND group) and 12 weeks or more (12-weeks-or-more ND group) after CRT. RESULTS: Sixty-seven NDs were performed less than 12 weeks and 38 were performed 12 weeks or more after CRT. Patient characteristics, treatment, and ND pathology results were comparable between the 2 ND groups. The incidence of complications between the less-than-12-weeks and the 12-weeks-or-more ND groups included major wound complications in 8 of 67 (11.9%) vs 1 of 38 (2.6%; P = .15), minor wound complications in 11 of 67 (16.4%) vs 4 of 38 (10.5%; P = .56), airway complications in 7 of 67 (10.4%) vs 2 of 38 (5.3%; P = .48), and systemic complications in 9 of 67 (13.4%) vs 2 of 38 (5.3%; P = .32). The number of patients with at least 1 complication was significantly smaller in the 12-weeks-or-more ND group (P = .04). Multivariate analysis showed that radical ND was significantly associated with an increased number of complications, and higher radiation doses approached significance (P = .05). Induction chemotherapy was associated with fewer wound complications (P = .01). There were no significant differences in overall survival (P = .82), progression-free survival (P = .77), or regional relapse (P = .54) between groups. Positive ND findings were associated with diminished progression-free and overall survival. CONCLUSION: These findings indicate that ND can be safely performed 12 weeks or more after CRT without adversely affecting surgical complications or survival variables.
OBJECTIVES: To determine the incidence of postchemoradiotherapy (post-CRT) neck dissection (ND) complications; to ascertain whether timing (< 12 vs ≥ 12 weeks) from CRT to ND or other factors are associated with increased complications; and to determine whether ND timing influences disease control or survival. DESIGN: Ten-year retrospective analysis. SETTING: Tertiary care center. PATIENTS: One hundred five patients with head and neck cancer undergoing ND after CRT. MAIN OUTCOME MEASURES: Complications and survival variables compared between groups undergoing ND less than 12 weeks (less-than-12-weeks ND group) and 12 weeks or more (12-weeks-or-more ND group) after CRT. RESULTS: Sixty-seven NDs were performed less than 12 weeks and 38 were performed 12 weeks or more after CRT. Patient characteristics, treatment, and ND pathology results were comparable between the 2 ND groups. The incidence of complications between the less-than-12-weeks and the 12-weeks-or-more ND groups included major wound complications in 8 of 67 (11.9%) vs 1 of 38 (2.6%; P = .15), minor wound complications in 11 of 67 (16.4%) vs 4 of 38 (10.5%; P = .56), airway complications in 7 of 67 (10.4%) vs 2 of 38 (5.3%; P = .48), and systemic complications in 9 of 67 (13.4%) vs 2 of 38 (5.3%; P = .32). The number of patients with at least 1 complication was significantly smaller in the 12-weeks-or-more ND group (P = .04). Multivariate analysis showed that radical ND was significantly associated with an increased number of complications, and higher radiation doses approached significance (P = .05). Induction chemotherapy was associated with fewer wound complications (P = .01). There were no significant differences in overall survival (P = .82), progression-free survival (P = .77), or regional relapse (P = .54) between groups. Positive ND findings were associated with diminished progression-free and overall survival. CONCLUSION: These findings indicate that ND can be safely performed 12 weeks or more after CRT without adversely affecting surgical complications or survival variables.
Authors: Claudia I Chapuy; Donald J Annino; Anna Snavely; Yi Li; Roy B Tishler; Charles M Norris; Robert I Haddad; Laura A Goguen Journal: Otolaryngol Head Neck Surg Date: 2011-09 Impact factor: 3.497
Authors: R Montal; M Oliva; M Taberna; L De Avila; A Rovira; M Cos; M Mañós; V Navarro; J Nogués; A Lozano; L Rodríguez; E Vilajosana; S Vázquez; R Mesia Journal: Clin Transl Oncol Date: 2016-03-10 Impact factor: 3.405
Authors: H Hakan Coskun; Jesus E Medina; K Thomas Robbins; Carl E Silver; Primož Strojan; Afshin Teymoortash; Phillip K Pellitteri; Juan P Rodrigo; Sandro J Stoeckli; Ashok R Shaha; Carlos Suárez; Dana M Hartl; Remco de Bree; Robert P Takes; Marc Hamoir; Karen T Pitman; Alessandra Rinaldo; Alfio Ferlito Journal: Head Neck Date: 2014-06-30 Impact factor: 3.147
Authors: William J Scotton; I J Nixon; T F Pezier; R Cobb; A Joshi; T Guerrero Urbano; R Oakley; J P Jeannon; R S Simo Journal: Eur Arch Otorhinolaryngol Date: 2013-10-17 Impact factor: 2.503
Authors: R Pellini; G Mercante; C Marchese; V Terenzi; I Sperduti; V Manciocco; P Ruscito; G Cristalli; P Marchesi; B Pichi; G Spriano Journal: Acta Otorhinolaryngol Ital Date: 2013-02 Impact factor: 2.124
Authors: Nils Helsen; Dessie Roothans; Bert Van Den Heuvel; Tim Van den Wyngaert; Danielle Van den Weyngaert; Laurens Carp; Sigrid Stroobants Journal: PLoS One Date: 2017-08-03 Impact factor: 3.240
Authors: William T Tran; Harini Suraweera; Karina Quaioit; Daniel Cardenas; Kai X Leong; Irene Karam; Ian Poon; Deok Jang; Lakshmanan Sannachi; Mehrdad Gangeh; Sami Tabbarah; Andrew Lagree; Ali Sadeghi-Naini; Gregory J Czarnota Journal: Future Sci OA Date: 2019-11-26
Authors: L Putten; R Bree; P A Doornaert; J Buter; S E J Eerenstein; D H F Rietveld; D J Kuik; C R Leemans Journal: Acta Otorhinolaryngol Ital Date: 2015-06 Impact factor: 2.124